Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Paul_Stoffels
|
| gptkbp:collaboratedWith |
gptkb:Gilead_Sciences
|
| gptkbp:country |
gptkb:Belgium
|
| gptkbp:focus |
oncology
inflammatory diseases fibrosis |
| gptkbp:founded |
1999
|
| gptkbp:founder |
Onno van de Stolpe
|
| gptkbp:headquarters_location |
gptkb:Mechelen,_Belgium
|
| https://www.w3.org/2000/01/rdf-schema#label |
Galapagos NV
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:ISIN |
BE0003818359
|
| gptkbp:numberOfEmployees |
~1,300
|
| gptkbp:product |
gptkb:filgotinib
GLPG1690 GLPG1972 |
| gptkbp:stockExchange |
gptkb:Euronext_Brussels
gptkb:Euronext_Amsterdam |
| gptkbp:stockSymbol |
GLPG
|
| gptkbp:website |
https://www.glpg.com/
|
| gptkbp:bfsParent |
gptkb:Daniel_O'Day
|
| gptkbp:bfsLayer |
7
|